Document is current
Any future updates will be listed below
-
Authors
Villanueva, Vicente
Soto-Insuga, Victor https://orcid.org/0000-0002-8358-2901
Smeyers, Patricia
Aledo-Serrano, Ángel
Sánchez-Carpintero, Rocío
García-Peñas, Juan
Gil-Nagel, Antonio
-
Funding
Funding for this research was provided by:
UCB Spain
- License Information
-
More Information
Article History
Received: 13 December 2024
Accepted: 29 January 2025
First Online: 23 February 2025
Declarations
:
: Vicente Villanueva has participated in advisory boards, research and symposium organized by: Angelini, Bial, Biocodex, Eisai Inc, Jazz Pharmaceuticals, Novartis, Paladin, Takeda, UCB, Xenon. Víctor Soto-Insuga has participated in advisory boards, research and educational activities supported or organized by: Biocodex, Eisai, Jazz Pharma, UCB. Patricia Smeyers Durá has participated in advisory boards, research and educational activities supported or organized by: Biocodex, Jazz Pharma, Neuraxpharm, UCB. Angel Aledo-Serrano has participated in advisory boards, research and educational activities supported or organized by: Angelini, Bial Biocodex, Eisai, Jazz Pharma, Takeda, UCB. Rocío Sánchez-Carpintero has participated in advisory boards, research and educational activities supported or organized by: Biocodex, Jazz Pharma, UCB. Juan Garcia-Peñas has participated in advisory boards, symposium and educational activities supported or organized by: Bial, Biogen, Eisai, Jazz, Nutricia, UCB and Sanofi. Antonio Gil-Nagel has participated in advisory boards, research and educational activities supported or organized by: Angelini, Bial, Biocodex, Biogen, Eisai, Jazz Pharma, Pharvaris, Oils 4 Cure, Praxis, Rapport Therapeutics, Stoke, and UCB Pharma.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
